Supernus Pharmaceuticals Inc (SUPN) — Cash Flow Quality Index
Supernus Pharmaceuticals Inc (SUPN) has a Cash Flow Quality Index of 2.60x as of June 2025. Operating cash flow of $58.53 Million exceeds net income of $22.50 Million, indicating high earnings quality where cash backs reported profits. Explore how well can Supernus Pharmaceuticals Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Supernus Pharmaceuticals Inc Cash Flow Quality Index (2009–2024)
Historical Cash Flow Quality Index for Supernus Pharmaceuticals Inc across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of Supernus Pharmaceuticals Inc.
Annual Cash Flow Quality Index for Supernus Pharmaceuticals Inc (2009–2024)
Year-by-year earnings quality comparison for Supernus Pharmaceuticals Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.33x | $171.95 Million | $73.86 Million | ▼ -97.2% |
| 2023 | 84.41x | $111.08 Million | $1.32 Million | ▲ +4286.6% |
| 2022 | 1.92x | $116.83 Million | $60.71 Million | ▼ -19.1% |
| 2021 | 2.38x | $127.13 Million | $53.42 Million | ▲ +118.3% |
| 2020 | 1.09x | $138.40 Million | $126.95 Million | ▼ -13.9% |
| 2019 | 1.27x | $143.13 Million | $113.06 Million | ▲ +8.9% |
| 2018 | 1.16x | $128.99 Million | $110.99 Million | ▼ -41.9% |
| 2017 | 2.00x | $114.64 Million | $57.28 Million | ▲ +173.2% |
| 2016 | 0.73x | $66.81 Million | $91.22 Million | ▼ -68.0% |
| 2015 | 2.29x | $32.12 Million | $14.02 Million | ▲ +488.9% |
| 2014 | 0.39x | $7.73 Million | $19.87 Million | ▼ -38.9% |
| 2009 | 0.64x | $2.63 Million | $4.14 Million | — |